Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland

Clostridium difficile is an important healthcare-associated pathogen, responsible for a broad spectrum of diarrheal diseases. The aim of this prospective study was to determine the occurrence of C. difficile infection (CDI), to characterize cultured C. difficile strains and to investigate the association of fecal lactoferrin with CDI. Between January 2013 and June 2014, 148 stool samples were obtained from adult diarrheal patients (C difficile as a suspected pathogen) hospitalized in different healthcare facilities of 15 Silesian hospitals. Out of 134 isolated C difficile strains, 108 were ribotyped: 82.4% belonged to Type 027, 2.8% to Type 176, 2.8% to Type 014,1.9% to Type 010 and 0.9% to Types 001, 018, 020 and 046 each. In total, 6.5% non-typable strains were identified. All Type 027 isolates contained both toxin genes tcdA & tcdB, and binary toxin genes (cdtA & cdtB). Susceptibility testing revealed that all Type 027 isolates were sensitive to metronidazole and vancomycin and resistant to moxifloxacin, ciprofloxacin, imipenem and erythromycin. Of 89 Type 027 strains, 16 had a ermB (688 bp) gene coinciding with high levels of erythromycin resistance (MIC >256 mu g/mL). Of 16 ermB positive strains, 14 demonstrated also high level of resistance to clindamycin (>256 mu g/mL). A significant difference (p = 0.004) in lactoferrin level was found between C difficile toxin-positive (n = 123; median 185.9 mu g/mL; IQR 238.8) and toxin-negative (n = 25; median 22.4 mu g/mL; IQR 141.7) fecal samples. Stool samples from n = 89 patients with CDI caused by Type 027 demonstrated significantly higher (p = 0.03) lactoferrin level (median 173.0 mu g/mL; IQR 2373) than from patients with CDI caused by other ribotypes and non-typable C difficile strains (median 189.4 mu g/mL; IQR 190.8). (C) 2017 Elsevier Ltd. All rights reserved.